Carvina Capital: Medline’s IPO Could Top Charts
In the current issuance window, Carvina Capital Pte. Ltd. highlights Medline Industries as the potential pace-setter for US new issues, with a proposed float that targets approximately $5 billion in gross proceeds at launch and contemplates an equity valuation near $50 billion at pricing. The timetable under discussion points to a public filing in the coming weeks and first trading shortly thereafter, subject to market conditions and regulatory...
Read more








